ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
failure to respond or late response
on 10 Jul 2023
Last Applicant/ Owned by
210 Hazelwood Dr., Ste 103
Champaign
IL
61820
Serial Number
88606951 filed on 06th Sep 2019
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
IMMUNIX
An automated system consisting of computer hardware, downloadable software and communications devices that characterize the immune state of a patient or group of patients by applying machine learning to compare a combination of clinical data and biological data taken from the current patient(s) to clinical, biological, and outcomes data from past patient datasets
Classification Information
Class [009]
Computer & Software Products & Electrical & Scientific Products
An automated system consisting of computer hardware, downloadable software and communications devices that characterize the immune state of a patient or group of patients by applying machine learning to compare a combination of clinical data and biological data taken from the current patient(s) to clinical, biological, and outcomes data from past patient datasets
First Use Date in General
15th Mar 2023
First Use Date in Commerce
15th Mar 2023
Specimens
Mark Details
Serial Number
No 88606951
Mark Type
No Service/Collective Mark
Attorney Docket Number
No Prenosis
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 10th Jul 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 10th Jul 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| 24th Mar 2023 | SU - NON-FINAL ACTION - WRITTEN |
| 24th Mar 2023 | NON-FINAL ACTION E-MAILED |
| 24th Mar 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 23rd Mar 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 17th Mar 2023 | TEAS STATEMENT OF USE RECEIVED |
| 17th Mar 2023 | USE AMENDMENT FILED |
| 04th Nov 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 03rd Nov 2022 | SOU EXTENSION 5 GRANTED |